The BC Cancer Foundation is launching a fundraising campaign to support the next three years of immunotherapy research at BC ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

From the death of a Netflix actress due to stomach cancer complications to an NFL star sharing his chemo experience, here is ...

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated ...

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, and prednisone against the current standard-of-care in patients with ...

Learn more about whether Biogen Inc. or Neurocrine Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

As pet owners, we dread the day our companions show signs of illness, but a vet has explained everything you need to know.

Las Palmas captain Kirian Rodriguez has revealed will stop playing for six months following confirmation that his Hodgkin ...

A lymphoma specialist who survived her own tumor surgery helps patients navigate the daunting decisions to be made.

The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...